Acarix

📍 Malmö, Sweden🗓 Founded 2009👥 30 employees💰 Last funded Jul 2011
Medical Device🌐 acarix.com
Website LinkedIn
Acarix is a Swedish medical device company that innovates solutions for rapid AI-based Coronary Artery Disease (CAD) rule-out. The CE-mark approved and FDA De Novo cleared Acarix CADScor®System is for patients experiencing chest pain with suspected CAD and is designed to help reduce millions of unnecessary, invasive, costly diagnostic procedures. CADScor®System calculates a patient-specific CAD-score non-invasively in less than 10 minutes with 96% confidence. Acarix is listed on the Nasdaq First North Premier Growth Market (ticker: ACARIX).
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2009
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Denmark
1
Frequently asked questions
Who invested in Acarix?
Acarix has 1 investors on record on gritt.io, including 1 early-stage backers.
When did Acarix last raise funding?
The most recent investment in Acarix recorded on gritt.io was in July 2011.
When was Acarix founded?
Acarix was founded in 2009.
What industry is Acarix in?
Acarix operates in Medical Device. Find similar Medical Device investors on gritt.io.
Where is Acarix based?
Acarix is headquartered in Malmö, Sweden.